JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8+ T cells in renal cell carcinoma patients

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Ranieri, Elena ^b   Cavalcanti, Elisabetta ^a   Gigante, Margherita ^b   Mancini, Vito ^a   Battaglia, Michele ^a   Ditonno, Pasquale ^a   Capobianco, Carmela ^a   Cincione, Raffaele I ^b   Selvaggi, Francesco P ^a   Herr, Wolfgang ^c   Storkus, Walter J ^d   Gesualdo, Loreto ^b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM 51; GAMMA INTERFERON; JANUS KINASE 3; STAT5 PROTEIN; STAT6 PROTEIN; CDKN1B PROTEIN, HUMAN; CHROMIUM; E2F4 PROTEIN, HUMAN; ID2 PROTEIN, HUMAN; INHIBITOR OF DIFFERENTIATION 2; JAK3 PROTEIN, HUMAN; SIGNAL PEPTIDE; STAT6 PROTEIN, HUMAN; TRANSCRIPTION FACTOR E2F4;

ARTICLE; CD8+ T LYMPHOCYTE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL DIVISION; CELL ISOLATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GENE OVEREXPRESSION; HLA SYSTEM; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MIXED LYMPHOCYTE CULTURE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TURNOVER TIME; CASE CONTROL STUDY; CELL CYCLE; CELL SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; IMMUNOLOGY; KIDNEY TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE;

CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; CELL CYCLE; CELL SURVIVAL; CHROMIUM ISOTOPES; E2F4 TRANSCRIPTION FACTOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 2; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JANUS KINASE 3; KIDNEY NEOPLASMS; LYMPHOCYTE CULTURE TEST, MIXED; MICROSCOPY, CONFOCAL; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED;

EID: 77951673112     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/935764     Document Type: Article

References (38)

1. Rini B. I., Campbell S. C., Rathmell W. K., Renal cell carcinoma Current Opinion in Oncology 2006 18 3 289 296 (Pubitemid 43740426)
2. Coppin C., Immunotherapy for renal cell cancer in the era of targeted therapy Expert Review of Anticancer Therapy 2008 8 6 907 919
3. Ngrier S., Perol D., Ravaud A., Randomized study of intravenous versus subcutaneous interleukin-2, and IFNalpha in patients with good prognosis metastatic renal cancer Clinical Cancer Research 2008 14 18 5907 5912
4. + T cells Journal of Immunology 2009 39 241 253
5. + T lymphocytes Nature 2003 421 6925 852 856 (Pubitemid 36254145)
6. Sallusto F., Geginat J., Lanzavecchia A., Central memory and effector memory T cell subsets: function, generation, and maintenance Annual Review of Immunology 2004 22 745 763 (Pubitemid 38680440)
7. + T cells confer superior antitumor immunity compared with effector memory T cells Proceedings of the National Academy of Sciences of the United States of America 2005 102 27 9571 9576 (Pubitemid 40981722)
8. + T cells derived from central memory cells establishes persistent T cell memory in primates Journal of Clinical Investigation 2008 118 1 294 305
9. + memory T-cell subsets in response to antigen or homeostatic cytokines Blood 2003 101 11 4260 4266 (Pubitemid 36857786)
10. + T subsets with distinct replicative history and partial effector functions Blood 2003 102 5 1779 1787 (Pubitemid 37022574)
11. + T cell subsets Journal of Immunology 2005 175 9 5895 5903 (Pubitemid 41508074)
12. Rane S. G., Reddy E. P., Janus kinases: components of multiple signaling pathways Oncogene 2000 19 5662 5579
13. Fero M. L., Rivkin M., Tasch M., A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p 27 Kip 1 -deficient Mice Cell 1996 85 5 733 744 (Pubitemid 126334353)
14. Nakayama K., Ishida N., Shirane M., Mice lacking p 27 Kip 1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary Tumors Cell 1996 85 5 707 720 (Pubitemid 126334351)
15. Kaplan M. H., Daniel C., Schindler U., Grusby M. J., Stat proteins control lymphocyte proliferation by regulating p 27 Kip 1 expression Molecular Biology of Eukaryotic Cells 1998 18 1996 2003
16. Shen R., Kaplan M. H., The homeostasis but not the differentiation of T cells is regulated by p 27 Kip 1 Journal of Immunology 2002 169 2 714 721
17. Rivoltini L., Canese P., Huber V., Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control? Expert Opinion on Biological Therapy 2005 5 463 476
18. Lea N. C., Orr S. J., Stoeber K., Commitment point during G 0 → G 1 that controls entry into the cell cycle Molecular and Cellular Biology 2003 23 7 2351 2361
19. Gaubatz S., Lindeman G. J., Ishida S., E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control Molecular Cell 2000 6 3 729 735
20. Dyson N., The regulation of E2F by pRB-family proteins Genes and Development 1998 12 15 2245 2262
21. Fang Z. H., Han Z. C., The transcription factor E2F: a crucial switch in the control of homeostasis and tumorigenesis Histology and Histopathology 2006 21 46 403 413
22. Lahn M., Khler G., Schmoor C., Processing of tumor tissues for vaccination with autologous tumor cells European Surgical Research 1997 29 4 292 302
23. + T cells Cancer Research 2006 66 23 11447 11454
24. + T lymphocytes Journal of Immunology 2007 178 7 4112 4119
25. + T cells differently expressing three cytolytic effector molecules Journal of Immunology 2006 177 7 4330 4340 (Pubitemid 44469761)
26. + T cells Journal of Experimental Medicine 2005 202 7 907 912 (Pubitemid 41396891)
27. + T cells reflecting their function: inverse correlation between quantitative expression of CD27 and cytotoxic effector function European Journal of Immunology 2004 34 4 999 1010 (Pubitemid 39255978)
28. Zhang S., Lawless V. A., Kaplan M. H., Cytokine-stimulated T lymphocyte proliferation is regulate by p 27 Kip 1 Journal of Immunology 2000 165 6270 6277
29. + T cell immunity Nature Immunology 2006 7 12 1317 1325 (Pubitemid 46111253)
30. Van Den Hove L. E., Van Gool S. W., Van Poppel H., Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma Clinical and Experimental Immunology 1997 109 3 501 509 (Pubitemid 27402320)
31. Gigante M., Blasi A., Loverre A., Dysfunctional DC subsets in RCC patients: ex vivo correction to yield an effective anti-cancer vaccine Molecular Immunology 2009 46 5 893 901
32. + cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression Blood 2004 104 8 2591 2599 (Pubitemid 39331865)
33. + T cells vary in differentiation phenotype in different persistent virus infections Nature Medicine 2002 8 4 379 385
34. Copier J., Dalgleish A. G., Britten C. M., Improving the efficacy of cancer immunotherapy European Journal of Cancer 2009 45 8 1424 1431
35. Gigante M., Mandic M., Wesa A. K., Interferon-alpha (IFN-alpha)- conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patients Journal of Immunotherapy 2008 31 254 262
36. + T-cell activation and defence against toxoplasma gondii infection in the brain Immunology 2009 127 2 187 195
37. Mller H., Bracken A. P., Vernell R., E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis Genes and Development 2001 15 3 267 285
38. Lasorella A., Iavarone A., Israel M. A., Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins Molecular and Cellular Biology 1996 16 6 2570 2578